Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
37.05
-0.79 (-2.09%)
At close: Sep 18, 2026, 4:00 PM EDT
37.63
+0.58 (1.57%)
After-hours: Sep 18, 2026, 7:37 PM EDT
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $269.15 million as of September 18, 2026. Its market cap has increased by 384.95% in one year.
Market Cap
269.15M
Enterprise Value
254.81M
1-Year Change
384.95%
Ranking
Category
Stock Price
$37.05
ChartMarket Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has increased from $193.50M to $269.15M, an increase of 39.09%. That is a compound annual growth rate of 3.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 269.10M | 1,021.25% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Upstream Bio | 290.83M |
| Immuneering | 288.55M |
| Fulcrum Therapeutics | 287.64M |
| Yarrow Bioscience | 284.53M |
| Pyxis Oncology | 284.42M |
| Greenwich LifeSciences | 269.93M |
| ProQR Therapeutics | 266.72M |
| AC Immune | 266.46M |